Doceree, a Parsipanny, NJ-based global network of physician-only platforms for programmatic messaging, raised USD 35m in Series B funding.
The round was led by Creaegis. Existing investors, Eight Roads Ventures, and F-Prime Capital, also participated in the round.
The company intends to use the funds to accelerate product development, augment technologies, scale global expansion, and expand team.
Founded in 2019 by Harshit Jain MD, Global CEO, Doceree is a global platform building solutions for healthcare professional (HCP) programmatic messaging with proprietary data tools. It facilitates messaging between life sciences brands and HCPs through an extensive global network of digital endemic and point-of-care platform.
The company has grown more than 100% in the last one year with monthly revenue rising five folds between the Series A funding in April 2022 and now. They introduced innovations on the demand and supply sides, including Doceree Enterprise, an HCP-focussed global Demand Side Platform (DSP), and Doceree Provider that empowers HCPs to improve health outcomes of their patients. Its HCP marketing ecosystem consists of custom-built solutions that equip life science marketers to engage with physicians at opportune moments with contextual messaging and evaluate campaign performances to improve script lift.
Its solutions are used in the US, Indian and European markets, as well as Africa, Southeast Asia (SEA), and the Gulf Cooperation Council (GCC).
FinSMEs
27/09/2023